Daiwa Securities Group
UTHR icon

Daiwa Securities Group’s United Therapeutics UTHR Stock Holding History

Daiwa Securities Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.76M Sell
6,334
-687
-10% -$342K 0.01% 527
2025
Q4 		$3.42M Buy
7,021
+3,179
+83% +$1.48M 0.01% 540
2025
Q3 		$1.61M Buy
3,842
+185
+5% +$62.2K 0.01% 682
2025
Q2 		$1.05M Buy
3,657
+10
+0.3% +$2.99K ﹤0.01% 742
2025
Q1 		$1.12M Sell
3,647
-634
-15% -$217K ﹤0.01% 708
2024
Q4 		$1.51M Buy
4,281
+162
+4% +$59.5K 0.01% 655
2024
Q3 		$1.48M Buy
4,119
+852
+26% +$288K 0.01% 652
2024
Q2 		$1.04M Sell
3,267
-410
-11% -$109K 0.01% 702
2024
Q1 		$845K Buy
3,677
+485
+15% +$109K ﹤0.01% 744
2023
Q4 		$702K Buy
3,192
+123
+4% +$28.4K ﹤0.01% 770
2023
Q3 		$693K Buy
3,069
+100
+3% +$23K ﹤0.01% 766
2023
Q2 		$655K Sell
2,969
-14
-0.5% -$3.1K ﹤0.01% 761
2023
Q1 		$668K Buy
2,983
+2,800
+1,530% +$690K ﹤0.01% 752
2022
Q4 		$51K Buy
183
+14
+8% +$3.53K ﹤0.01% 1036
2022
Q3 		$35K Hold
169
– – ﹤0.01% 1080
2022
Q2 		$40K Buy
169
+38
+29% +$7.72K ﹤0.01% 1095
2022
Q1 		$24K Hold
131
– – ﹤0.01% 1106
2021
Q4 		$28K Sell
131
-23
-15% -$4.51K ﹤0.01% 1106
2021
Q3 		$28K Buy
154
+66
+75% +$13K ﹤0.01% 1090
2021
Q2 		$16K Hold
88
– – ﹤0.01% 1027
2021
Q1 		$15K Buy
88
+4
+5% +$667 ﹤0.01% 1025
2020
Q4 		$13K Sell
84
-164
-66% -$21.5K ﹤0.01% 1004
2020
Q3 		$25K Hold
248
– – ﹤0.01% 976
2020
Q2 		$24K Hold
248
– – ﹤0.01% 1017
2020
Q1 		$24K Hold
248
– – ﹤0.01% 998
2019
Q4 		$22K Sell
248
-30
-11% -$2.64K ﹤0.01% 1007
2019
Q3 		$22K Hold
278
– – ﹤0.01% 992
2019
Q2 		$22K Sell
278
-1,500
-84% -$140K ﹤0.01% 1006
2019
Q1 		$209K Sell
1,778
-21
-1% -$2.45K ﹤0.01% 861
2018
Q4 		$196K Buy
1,799
+210
+13% +$24.3K ﹤0.01% 822
2018
Q3 		$203K Hold
1,589
– – ﹤0.01% 856
2018
Q2 		$180K Hold
1,589
– – ﹤0.01% 884
2018
Q1 		$179K Buy
1,589
+239
+18% +$30.4K ﹤0.01% 860
2017
Q4 		$200K Hold
1,350
– – ﹤0.01% 847
2017
Q3 		$158K Hold
1,350
– – ﹤0.01% 848
2017
Q2 		$175K Hold
1,350
– – ﹤0.01% 830
2017
Q1 		$183K Buy
1,350
+200
+17% +$30.3K ﹤0.01% 806
2016
Q4 		$165K Hold
1,150
– – ﹤0.01% 811
2016
Q3 		$136K Buy
1,150
+100
+10% +$12K ﹤0.01% 763
2016
Q2 		$111K Buy
1,050
+150
+17% +$16.7K ﹤0.01% 787
2016
Q1 		$100K Sell
900
-7,000
-89% -$886K ﹤0.01% 810
2015
Q4 		$1.24M Buy
7,900
+7,000
+778% +$1.02M 0.01% 325
2015
Q3 		$118K Sell
900
-1,800
-67% -$289K ﹤0.01% 784
2015
Q2 		$470K Buy
+2,700
New +$486K ﹤0.01% 540

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Daiwa Securities Group's UTHR Position: Q1 2026 in Review

Daiwa Securities Group reduced its United Therapeutics (UTHR) stake by 9.8% in Q1 2026, selling an estimated $342K and leaving 6,334 shares worth $3.76M. The position accounts for 0.01% of the portfolio, ranked #527.

Daiwa Securities Group first reported a position in UTHR in Q2 2015 and has held it in 44 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Daiwa Securities Group held 6,334 shares of United Therapeutics worth $3.76M as of Q1 2026.
  • Daiwa Securities Group sold 687 United Therapeutics shares in Q1 2026, an estimated $342K.
  • United Therapeutics made up 0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #527 holding.
  • Daiwa Securities Group first reported a position in United Therapeutics in Q2 2015 and has held it in 44 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.